Search results
Chronic Lymphocytic Leukemia: Slow-Appearing Symptoms
Verywell Health via Yahoo News· 10 months agoNew therapies are transforming treatment Halfpoint Images / Getty Images Medically reviewed by...
What Makes Being Diagnosed with CLL So Surprising
Good Housekeeping via Yahoo News· 1 year agoWhat to Expect From a CLL DiagnosisMorsa Images - Getty Images Having someone say the words “you have cancer” can be one of the most surreal moments of...
What Is Leukemia?
Verywell Health via Yahoo News· 1 year agoLeukemia is a form of blood cancer that starts in your bone marrow, the spongy tissue inside your bones. It occurs when abnormal cells grow too fast and...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi's Label Expansion
Zacks via Yahoo Finance· 3 months agoBristol Myers (BMY) obtains FDA approval for the label expansion of CAR T cell therapy, Breyanzi,...
US FDA gives second approval to Eli Lilly's drug for type of blood cancer
Reuters via Yahoo News· 6 months agoThe company said the health regulator gave the new approval to the drug for the treatment of chronic...
LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Cancer Program
Benzinga via Yahoo Finance· 2 years agoLAVA Therapeutics N.V. (NASDAQ: LVTX) hosted a clinical update call focused on initial Phase 1/2a...
Short bouts of exercise may boost efficacy of some types of cancer treatment
MedicalNewsToday via AOL· 2 days agoRecent research suggests that short bouts of moderate to intense exercise could boost the efficacy...
Bristol Myers cell therapy wins first-of-its-kind approval
BioPharma Dive via Yahoo Finance· 3 months agoSold as Breyanzi, the therapy is now cleared for use in certain adults with hard-to-treat forms of...
Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study
Zacks via Yahoo Finance· 2 months agoNurix (NRIX) rises on initial findings of clinical responses in the brain for its investigational...
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
InvestorPlace via Yahoo Finance· 8 months agoAutologous chimeric antigen receptor T cell therapy is 0ne of the most promising, relatively new...